2026-03-18 08:05
Biovica, a leader in blood-based biomarkers for cancer treatment monitoring, today announces two poster presentations at the American Association for Cancer Research (AACR) Annual Meeting. The studies expand the evidence for circulating thymidine kinase...
2026-03-18 08:00
46% growth with strong momentum in the USA and for Pharma Services Q3 (Nov 2025–Jan 2026) (comparison figures are for the same period 2024/2025) Q1–Q3 (May 2025–Jan2026) (comparison figures are for the same period 2024/2025) Significant...
2026-03-09 17:00
The Nomination Committee prior to the 2026 Annual General Meeting will consist of four members, who shall represent the three shareholders with the highest number of shares who accept the assignment to be part of the Nomination Committee as of December...
2026-03-05 15:30
The Board of Directors of Biovica International AB today announces that Chief Executive Officer Anders Rylander has informed the Board of his intention to step down as CEO during 2026, as part of a structured succession process. Anders Rylander will remain...
2026-02-12 08:30
Biovica, a leader in blood-based cancer monitoring, today announces that results from the prospective PDM‑MBC (Personalised Disease Monitoring in Metastatic Breast Cancer) study have been published in Breast Cancer Research and Treatment. The results...
2026-01-27 08:30
Biovica, a leader in blood-based cancer monitoring, today announced that DiviTum TKa data from the Ciclib trial at Roswell Park have been published in JCO Precision Oncology. Results show that thymidine kinase activity (TKa) measured in blood can predict...
2025-12-18 08:30
Positioned for growth in Pharma Services and in the USA Q2 (August– October 2025) (comparison figures same period 2024) Q1 and Q2 (May – October 2025) (comparison figures same period 2024) Significant events during Q2 (August – October...
2025-12-15 08:30
Biovica, a leader in blood-based cancer monitoring, today announced that the company has entered into a commercial agreement (client bill agreement) with a leading U.S. NCI-designated Comprehensive Cancer Center. The agreement enables clinicians at the...
2025-11-26 08:45
Biovica, a leader in blood-based cancer monitoring, today announces the presentation of two new abstracts at the 2025 San Antonio Breast Cancer Symposium (SABCS). Both studies highlight the clinical relevance of DiviTum® TKa as a dynamic biomarker...
2025-09-23 12:00
The annual general meeting of Biovica International AB ("Biovica" or the "Company") was held today on 23 September 2025 and the following resolutions were passed by the meeting. Adoption of the income statement and balance sheetThe...
>4,500
Numbers of patients in studies
28
Publications
32
Pharma Projects